Literature DB >> 33578685

Custom-Made Zirconium Dioxide Implants for Craniofacial Bone Reconstruction.

Marcin Kozakiewicz1, Tomasz Gmyrek1, Radosław Zajdel2, Bartłomiej Konieczny3.   

Abstract

Reconstruction of the facial skeleton is challenging for surgeons because of difficulties in proper shape restoration and maintenance of the proper long-term effect. ZrO2 implant application can be a solution with many advantages (e.g., osseointegration, stability, and radio-opaqueness) and lacks the disadvantages of other biomaterials (e.g., metalosis, radiotransparency, and no osseointegration) or autologous bone (e.g., morbidity, resorption, and low accuracy). We aimed to evaluate the possibility of using ZrO2 implants as a new application of this material for craniofacial bone defect reconstruction. First, osteoblast (skeleton-related cell) cytotoxicity and genotoxicity were determined in vitro by comparing ZrO2 implants and alumina particle air-abraded ZrO2 implants to the following: 1. a titanium alloy (standard material); 2. ultrahigh-molecular-weight polyethylene (a modern material used in orbital surgery); 3. a negative control (minimally cytotoxic or genotoxic agent action); 4. a positive control (maximally cytotoxic or genotoxic agent action). Next, 14 custom in vivo clinical ZrO2 implants were manufactured for post-traumatologic periorbital region reconstruction. The soft tissue position improvement in photogrammetry was recorded, and clinical follow-up was conducted at least 6 years postoperatively. All the investigated materials revealed no cytotoxicity. Alumina particle air-abraded ZrO2 implants showed genotoxicity compared to those without subjection to air abrasion ZrO2, which were not genotoxic. The 6-month and 6- to 8-year clinical results were aesthetic and stable. Skeleton reconstructions using osseointegrated, radio-opaque, personalized implants comprising ZrO2 material are the next option for craniofacial surgery.

Entities:  

Keywords:  bone defect treatment; craniofacial; custom implants; cytotoxicity; genotoxicity; maxillofacial surgery; titanium alloy; ultrahigh molecular weight polyethylene; zirconium dioxide

Year:  2021        PMID: 33578685      PMCID: PMC7916391          DOI: 10.3390/ma14040840

Source DB:  PubMed          Journal:  Materials (Basel)        ISSN: 1996-1944            Impact factor:   3.623


  48 in total

1.  Rigid fixation of internal orbital fractures.

Authors:  R D Glassman; P N Manson; C A Vanderkolk; N T Iliff; M J Yaremchuk; P Petty; C R Defresne; B L Markowitz
Journal:  Plast Reconstr Surg       Date:  1990-12       Impact factor: 4.730

2.  Delayed fracture of a ceramic insert with modern ceramic total hip replacement.

Authors:  Byung-Woo Min; Kwang-Soon Song; Chul-Hyung Kang; Ki-Cheol Bae; Ye-Yeon Won; Kwon-Yong Lee
Journal:  J Arthroplasty       Date:  2006-06-21       Impact factor: 4.757

Review 3.  Orbital blowout fractures: a ten-year survey.

Authors:  J M Converse; B Smith; M F Obear; D Wood-Smith
Journal:  Plast Reconstr Surg       Date:  1967-01       Impact factor: 4.730

4.  Complications of harvesting cranial bone grafts.

Authors:  M Keen
Journal:  Plast Reconstr Surg       Date:  1995-12       Impact factor: 4.730

5.  Secondary correction of traumatogenic enophthalmos with auto- and alloplastic implants.

Authors:  A Hemprich; T Breier
Journal:  Rev Stomatol Chir Maxillofac       Date:  1993

6.  Influence of titanium ion on mineral formation and properties of osteoid nodules in rat calvaria cultures.

Authors:  H Liao; T Wurtz; J Li
Journal:  J Biomed Mater Res       Date:  1999-11

7.  Inflammatory infiltrate, microvessel density, nitric oxide synthase expression, vascular endothelial growth factor expression, and proliferative activity in peri-implant soft tissues around titanium and zirconium oxide healing caps.

Authors:  Marco Degidi; Luciano Artese; Antonio Scarano; Vittoria Perrotti; Peter Gehrke; Adriano Piattelli
Journal:  J Periodontol       Date:  2006-01       Impact factor: 6.993

8.  Titanium and zirconia particle-induced pro-inflammatory gene expression in cultured macrophages and osteolysis, inflammatory hyperalgesia and edema in vivo.

Authors:  G A Obando-Pereda; L Fischer; D R Stach-Machado
Journal:  Life Sci       Date:  2013-11-16       Impact factor: 5.037

9.  Treatment with individual orbital wall implants in humans - 1-Year ophthalmologic evaluation.

Authors:  Marcin Kozakiewicz; Marcin Elgalal; Loba Piotr; Anna Broniarczyk-Loba; Ludomir Stefanczyk
Journal:  J Craniomaxillofac Surg       Date:  2010-04-22       Impact factor: 2.078

10.  Osteoconductive Microarchitecture of Bone Substitutes for Bone Regeneration Revisited.

Authors:  Chafik Ghayor; Franz E Weber
Journal:  Front Physiol       Date:  2018-07-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.